Jeanine (Dienogest, Ethinylestradiol)

The ethinylestradiol component stabilises the endometrium and suppresses follicle‑stimulating hormone, while dienogest blocks the luteinising hormone surge that triggers ovulation. Together they also thicken cervical mucus and alter the uterine lining, reducing the chances of fertilisation and implantation.

The dosing regimen for Jeanine is determined by the prescribing clinician. Typically, the medication is taken as one tablet daily, at the same time each day, but the exact schedule and duration should follow the prescriber’s instructions.

Jeanine is classified as pregnancy category X, meaning it must not be used during pregnancy because it can harm the fetus. It is also not recommended for breastfeeding women, as hormonal exposure may affect milk production and infant health.

To order Jeanine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Jeanine contains dienogest, a progestogen with a lower androgenic profile, combined with ethinylestradiol. Compared with other pills that use levonorgestrel or desogestrel, Jeanine may offer similar contraceptive efficacy while potentially causing fewer androgen‑related side effects such as acne.

Jeanine tablets should be stored at room temperature, below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Jeanine is taken orally as a tablet, usually once each day. It is recommended to ingest the tablet at the same time each day, with or without food, to maintain consistent hormone levels and maximise contraceptive effectiveness.

The most serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe hypertension, liver dysfunction, and rare but potentially life‑threatening allergic reactions. Patients should seek immediate medical attention if they experience symptoms like chest pain, sudden shortness of breath, severe abdominal pain, or swelling of the face and throat.

Jeanine should not be used by women who are pregnant, have a history of blood clots, uncontrolled hypertension, severe liver disease, breast cancer, or who smoke more than 15 cigarettes per day. It is also contraindicated in individuals with known hypersensitivity to dienogest, ethinylestradiol or any tablet excipients.